MedTrace Logo

Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye

NCT00514852 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 316

Last updated 2009-12-15

Study results available
· View outcomes & findings →

Summary

The efficacy, safety and acceptability of a new artificial tear in subjects with dry eye will be compared to a currently-available artificial tear

Conditions

  • Dry Eye Syndrome

Interventions

DRUG

Carboxymethylcellulose and Glycerin based artificial tear

1 to 2 drops into each eye as needed but at least twice daily

DRUG

Carboxymethylcellulose

1 to 2 drops into each eye as needed but at least twice daily

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00514852 on ClinicalTrials.gov